Leon Hooftman
Impact in
- Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments
- Nephrology top 10%
- Renal Diseases and Glomerulopathies
Papers in
- Oncology 15
- Peptidase Inhibition and Analysis 8
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 4
- Co-authors
- Timothy H. Mathew (3 shared papers)Carl G. Groth (1 shared paper)C F Barker (1 shared paper)Stephen J. Tomlanovich (1 shared paper)Philip F. Halloran (1 shared paper)Ashok Rakhit (3 shared papers)Karen Rittweger (3 shared papers)Eleanor L. Ramos (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (6 papers)Clinical Cancer Research (3 papers)Annals of Oncology (3 papers)Transplantation (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Leon Hooftman
35 papers receiving 1.2k citations
Leon Hooftman's Hit Papers
Peers
Comparison fields: 5 of 73
- Transplantation 510
- Nephrology 67
- Hematology 106
- Psychiatry and Mental health 124
- Oncology 197
Countries citing papers authored by Leon Hooftman
This map shows the geographic impact of Leon Hooftman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Hooftman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Hooftman more than expected).
Fields of papers citing papers by Leon Hooftman
This network shows the impact of papers produced by Leon Hooftman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Hooftman. The network helps show where Leon Hooftman may publish in the future.
Co-authors
The 25 scholars most cited alongside Leon Hooftman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS Hit paper breakdown → | 1997 | 468 |
| 2 | 2003 | 111 | |
| 3 | 2001 | 73 | |
| 4 | 2012 | 67 | |
| 5 | 1997 | 66 | |
| 6 | 2010 | 60 | |
| 7 | 2009 | 44 | |
| 8 | 2019 | 42 | |
| 9 | 2017 | 38 | |
| 10 | 2002 | 38 | |
| 11 | 2013 | 36 | |
| 12 | 2009 | 30 | |
| 13 | 2005 | 26 | |
| 14 | 2010 | 22 | |
| 15 | 2024 | 11 | |
| 16 | 2013 | 10 | |
| 17 | 2023 | 5 | |
| 18 | 2004 | 5 | |
| 19 | Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers. | 1994 | 5 |
| 20 | 2024 | 4 |
About Leon Hooftman
Leon Hooftman is a scholar working on Oncology, Molecular Biology, Hematology, Pulmonary and Respiratory Medicine and Transplantation, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Histone Deacetylase Inhibitors Research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers), Renal Transplantation Outcomes and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Transplantation (510 citations), Nephrology (67 citations), Hematology (106 citations), Psychiatry and Mental health (124 citations) and Oncology (197 citations). Leon Hooftman has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Timothy H. Mathew, Carl G. Groth, C F Barker, Stephen J. Tomlanovich, Philip F. Halloran, Ashok Rakhit, Karen Rittweger, Eleanor L. Ramos, Timo Paavonen and E Taskinen. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Annals of Oncology and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.